Albany Molecular Research Inc (AMRI)

16.60
0.37 2.30
NASDAQ : Health Care
Prev Close 16.23
Open 16.41
Day Low/High 16.41 / 16.79
52 Wk Low/High 12.45 / 22.48
Volume 44.52K
Avg Volume 236.80K
Exchange NASDAQ
Shares Outstanding 42.89M
Market Cap 702.98M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Albany Molecular Research Becomes Oversold (AMRI)

Albany Molecular Research Becomes Oversold (AMRI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AMRI: Insiders vs. Shorts

AMRI: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/29/2016 settlement date, and Albany Molecular Research Inc is one of the most shorted stocks of the Russell 3000, based on 17.15 "days to cover" versus the median component at 6.42. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

AMRI Completes Acquisition Of Euticals

AMRI Completes Acquisition Of Euticals

AMRI: Insiders vs. Shorts

AMRI: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Albany Molecular Research Inc is one of the most shorted stocks of the Russell 3000, based on 20.08 "days to cover" versus the median component at 6.16. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

AMRI Clarifies 2016 Revenue Guidance

AMRI Clarifies 2016 Revenue Guidance

Albany Molecular Research (AMRI) Is Weak On High Volume Today

Albany Molecular Research (AMRI) Is Weak On High Volume Today

Trade-Ideas LLC identified Albany Molecular Research (AMRI) as a weak on high relative volume candidate

Commit To Buy Albany Molecular Research At $12.50, Earn 13.3% Annualized Using Options

Commit To Buy Albany Molecular Research At $12.50, Earn 13.3% Annualized Using Options

Investors considering a purchase of Albany Molecular Research, Inc. shares, but tentative about paying the going market price of $14.70/share, might benefit from considering selling puts among the alternative strategies at their disposal.